Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
This study will investigate the effect of a single oral dose of moxidectin on the QT interval
associated with moxidectin plasma concentrations.
The effect of moxidectin on other ECG intervals, and on safety, will also be assessed, as
will preliminary pharmacokinetics and metabolism
Phase:
Phase 1
Details
Lead Sponsor:
Medicines Development for Global Health Medicines Development Limited